The effect of bitter honey against cerebral malaria-induced inflammasome cell death: network pharmacology-based in silico evaluation

  
Daniyan M.O.1 , Adeoye O.B.2, Osirim E.3, Asiyanbola I.D.4

1. Faculty of Pharmacy, Obafemi Awolowo University, Ile-Ife, Osun State, Nigeria
2. Benjamin Carson (Snr.) School of Basic Medical Sciences, Babcock University, Ilishan-Remo, Ogun State, Nigeria
3. Faculty of Pharmacy, Obafemi Awolowo University, Ile-Ife, Osun State, Nigeria; Faculty of Basic Medical Science, Redeemer's University, Ede, Osun State, Nigeria
4. Faculty of Pharmacy, Obafemi Awolowo University, Ile-Ife, Osun State, Nigeria; College of Health Sciences, Osun State University, Osogbo, Osun State, Nigeria
Section: Experimental Study
DOI: 10.18097/PBMC20247006442      PubMed Id: 39718108
Year: 2024  Volume: 70  Issue: 6  Pages: 442-455
Cerebral malaria (CM) is a fatal complication of Plasmodium falciparum infection. The biological and physiological links between CM, inflammation, and inflammasome, point to the complexity of its pathology. Resistance to available and affordable drugs, worsening economic crisis, and urgent need for integration of orthodox with traditional/alternative medicine, actualized the search for sustainable pharmacotherapy. Previous works from our team on the medicinal properties of bitter honey have established botanical and bioactive markers, inhibitory effects on pancreatic alpha-amylase activity, and anti-dyslipidemia, cardio-protective, and ameliorative effects on hepatorenal damage in streptozotocin-induced diabetic rats. In this study, we have identified bitter honey (BH) derived phytochemicals using gas chromatography coupled with mass spectrometry (GC-MS), and 9 targets from genes associated with CM, inflammation, inflammasome, and BH phytochemicals. Network analysis revealed significant functional and physical interactions among these targets and NOD-, LRR-, and pyrin domain-containing protein 3 (NLRP3). Molecular docking of bitter honey-derived phytochemicals against these targets identified 3 most promising phytochemical candidates for further experimental validation. Based on these results, we predict that bitter honey may aid in the suppression of CM-mediated inflammasome cell death via its interactions with these targets.
Download PDF:  
Keywords: cerebral malaria, inflammation, inflammasome, bitter honey, phytochemicals, network pharmacology
Supplementary materials:
Citation:

Daniyan, M. O., Adeoye, O. B., Osirim, E., Asiyanbola, I. D. (2024). The effect of bitter honey against cerebral malaria-induced inflammasome cell death: network pharmacology-based in silico evaluation. Biomeditsinskaya Khimiya, 70(6), 442-455.
References  
 2024 (vol 70)
 2023 (vol 69)
 2022 (vol 68)
 2021 (vol 67)
 2020 (vol 66)
 2019 (vol 65)
 2018 (vol 64)
 2017 (vol 63)
 2016 (vol 62)
 2015 (vol 61)
 2014 (vol 60)
 2013 (vol 59)
 2012 (vol 58)
 2011 (vol 57)
 2010 (vol 56)
 2009 (vol 55)
 2008 (vol 54)
 2007 (vol 53)
 2006 (vol 52)
 2005 (vol 51)
 2004 (vol 50)
 2003 (vol 49)